Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-23-002454
Filing Date
2023-11-03
Accepted
2023-11-03 17:03:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d10820snse_11032023.htm SC 13D 222385
2 OFFER LETTER, DATED OCTOBER 25, 2023 ex991to13d10820snse_11032023.pdf SC 13D 1086477
3 JOINT FILING AGREEMENT, DATED NOVEMBER 3, 2023 ex992to13d10820snse_11032023.htm EX-99.2 14790
  Complete submission text file 0000921895-23-002454.txt   1734690
Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

EIN.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Subject) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92222 | Film No.: 231377217
SIC: 2834 Pharmaceutical Preparations